Cargando…

Graded-dosing immunization in adults at risk for immediate-type reactions to mRNA SARS-CoV-2 vaccines

Detalles Bibliográficos
Autores principales:	Stehlin, Florian, Tommasini, Francesco, Monzambani-Banderet, Véronique, Girard, Cedric, Yerly, Daniel, Ribi, Camillo, Muller, Yannick D.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Japanese Society of Allergology. Published by Elsevier B.V. 2023
Materias:	Letter to the Editor
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9595453/ https://www.ncbi.nlm.nih.gov/pubmed/36280516 http://dx.doi.org/10.1016/j.alit.2022.10.001

Ejemplares similares

Intradermal Testing With COVID-19 mRNA Vaccines Predicts Tolerance
por: Stehlin, Florian, et al.
Publicado: (2022)

Basophil activation tests with cryopreserved mRNA-based COVID-19 vaccines
por: Alcaraz-Serna, Ana, et al.
Publicado: (2023)

Clinical and immunological data from chronic urticaria onset after mRNA SARS‐CoV‐2 vaccines
por: Pescosolido, Eva, et al.
Publicado: (2022)

Safety and efficacy of graded dosing of Pfizer-BioNTech mRNA COVID-19 vaccine after an immediate hypersensitivity reaction to first dose
por: Regula, Prudhvi, et al.
Publicado: (2022)

Administration of the Second Dose of mRNA COVID-19 Vaccine to a Woman With Immediate Reaction to the First Dose
por: Apostolidou, Evaggelia, et al.
Publicado: (2023)

Immediate reactions after mRNA SARS-CoV-2 vaccination
por: Jeimy, Samira, et al.
Publicado: (2021)

Second-dose mRNA COVID-19 vaccine safety in patients with immediate reactions after the first dose: A case series
por: Iaboni, Aled, et al.
Publicado: (2022)

Clinical Phenotypes of Immediate First-Dose Reactions to mRNA COVID-19: A Multicenter Latent Class Analysis
por: Stone, Cosby A., et al.
Publicado: (2023)

Eosinophilic Granulomatosis with Polyangiitis after mRNA-1273 SARS-CoV-2 Vaccine
por: Mencarelli, Lucrezia, et al.
Publicado: (2023)

Management of Beta-Lactam Antibiotics Allergy: A Real-Life Study
por: Iuliano, Sarah, et al.
Publicado: (2022)

TOLERABILITY OF GRADED CORONAVIRUS DISEASE 2019 MRNA VACCINE DOSING
por: Hamel, B., et al.
Publicado: (2022)

Incidence of Chronic Spontaneous Urticaria Following Receipt of the COVID-19 Vaccine Booster in Switzerland
por: Duperrex, Olivier, et al.
Publicado: (2023)

Autoimmune Hemolytic Anemia and Pulmonary Embolism: An Association to Consider
por: Solari, Daria, et al.
Publicado: (2021)

The Fatigue Assessment Scale as a simple and reliable tool in systemic lupus erythematosus: a cross-sectional study
por: Horisberger, Alice, et al.
Publicado: (2019)

Long‐term outcomes in corticosteroid‐refractory Graves' orbitopathy treated with tocilizumab
por: Moi, Laura, et al.
Publicado: (2021)

mrna-1273: Immediate hypersensitivity: case report
Publicado: (2021)

Allergists Can Safely Evaluate and Revaccinate Individuals With Immediate Allergic Reactions to mRNA COVID-19 Vaccines
por: Greenhawt, Matthew, et al.
Publicado: (2021)

Impact of COVID-19 pandemic on SLE: beyond the risk of infection
por: Horisberger, Alice, et al.
Publicado: (2020)

183 Incidence of Systemic Reactions (SRS) to Prick (P) and Intradermal (ID) Tests, Response to Immediate (“STAT”) Epinephrine IM (EPI IM) Dose versus BMI, Number of Delayed SRS, and WAO Systemic Reaction Grade
por: Shearer, Dona, et al.
Publicado: (2012)

Central retinal vein occlusion occurring immediately after 2nd dose of mRNA SARS-CoV-2 vaccine
por: Bialasiewicz, A. A., et al.
Publicado: (2021)

Incidence of immediate allergic reactions to mRNA COVID-19 vaccines in adults with drug allergies and other allergic disorders
por: Marković, Ivan, et al.
Publicado: (2022)

Incidence and Risk Factors of Immediate Hypersensitivity Reactions and Immunization Stress-Related Responses With COVID-19 mRNA Vaccine
por: Imai, Kazuo, et al.
Publicado: (2022)

IMMUNOLOGICAL SPECIFICITY OF DELAYED AND IMMEDIATE HYPERSENSITIVITY REACTIONS
por: Benacerraf, B., et al.
Publicado: (1962)

THE PHYSIOLOGY OF THE IMMEDIATE REACTION OF ANAPHYLAXIS IN THE GUINEA-PIG
por: Auer, John, et al.
Publicado: (1910)

Diagnosis and Management of Immediate Hypersensitivity Reactions to Cephalosporins
por: Kim, Min-Hye, et al.
Publicado: (2014)

A Case of Immediate Hypersensitivity Reaction to Maltitol
por: Rodríguez Trabado, Ana, et al.
Publicado: (2017)

Delayed Hypersensitivity Reactions Following First Dose of the SARS-CoV2 mRNA Vaccines
por: Xu, Jennifer, et al.
Publicado: (2021)

Humoral response to a fourth dose of mRNA vaccine in kidney transplant recipient responders to three doses of mRNA vaccine
por: de Nattes, Tristan, et al.
Publicado: (2022)

Livedoid skin reaction to 2nd dose of mRNA Covid-19 vaccine
por: Girolami, Ilaria, et al.
Publicado: (2022)

Immediate-type infliximab infusion reaction presenting as purpura
por: Soong, Laura, et al.
Publicado: (2018)

Editorial: The Role of Mast Cells in Immediate Hypersensitivity Reactions
por: Aun, Marcelo Vivolo, et al.
Publicado: (2021)

Tozinameran: Immediate hypersensitivity reaction: 3 case reports
Publicado: (2022)

Tozinameran: Immediate allergic reaction: 22 case reports
Publicado: (2022)

Management of patients with immediate reactions to COVID-19 vaccines
por: Picard, Matthieu, et al.
Publicado: (2023)

Delayed skin reactions after the second dose of mRNA vaccines against SARS-CoV-2
por: Martins-Filho, Paulo Ricardo, et al.
Publicado: (2022)

Immediate and non-immediate allergic reactions to amoxicillin present a diagnostic dilemma: a case series
por: Weisser, Caroline, et al.
Publicado: (2016)

Assessment of immediate and non-immediate hypersensitivity contrast reactions by skin tests and provocation tests: A review
por: Bansie, Rakesh D, et al.
Publicado: (2021)

Antibody response to graded dosing of coronavirus disease 2019 messenger RNA vaccines after allergic reaction to first dose
por: Van Meerbeke, Sara W., et al.
Publicado: (2022)

Graded Administration of Second Dose of Moderna and Pfizer-BioNTech COVID-19 mRNA Vaccines in Patients With Hypersensitivity to First Dose
por: Tuong, Linh-An C, et al.
Publicado: (2021)

Immediate Reactions After the First Dose of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Messenger RNA Vaccines Do Not Preclude Second-Dose Administration
por: Vanijcharoenkarn, Kristine, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_g80a618gu11sokt6rr4tstndku